FDA Inspection 1180935 — Mission Pharmacal Company
The FDA completed an inspection of Mission Pharmacal Company on September 22, 2022 in Boerne, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 22, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Boerne, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 3559 | 21 CFR 211.56(a) | Sanitation--buildings not clean, free of infestation |
| 4576 | 21 CFR 211.192 | No written record of investigation |